Brad A. Racette, M.D. - Publications

Affiliations: 
Neurology Washington University, Saint Louis, St. Louis, MO 
Area:
Movement disorders, Epidemiology
Website:
http://neuro.wustl.edu/aboutus/facultybiographies/racette/

117 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Searles Nielsen S, Gross A, Camacho-Soto A, Willis AW, Racette BA. β2-adrenoreceptor medications and risk of Parkinson disease. Annals of Neurology. PMID 30225948 DOI: 10.1002/ana.25341  0.48
2018 Criswell SR, Warden MN, Searles Nielsen S, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. Selective D2 receptor PET in manganese-exposed workers. Neurology. PMID 30097475 DOI: 10.1212/WNL.0000000000006163  1
2018 Racette BA, Gross A, Vouri SM, Camacho-Soto A, Willis AW, Searles Nielsen S. Immunosuppressants and risk of Parkinson disease. Annals of Clinical and Translational Neurology. 5: 870-875. PMID 30009205 DOI: 10.1002/acn3.580  0.48
2017 Searles Nielsen S, Warden MN, Camacho-Soto A, Willis AW, Wright BA, Racette BA. A predictive model to identify Parkinson disease from administrative claims data. Neurology. PMID 28864676 DOI: 10.1212/WNL.0000000000004536  0.48
2017 Criswell SR, Nielsen SS, Warden M, Perlmutter JS, Moerlein SM, Flores HP, Huang J, Sheppard L, Seixas N, Checkoway H, Racette BA. [(18)F]FDOPA Positron Emission Tomography in Manganese-Exposed Workers. Neurotoxicology. PMID 28694016 DOI: 10.1016/j.neuro.2017.07.004  1
2017 Searles Nielsen S, Hu SC, Checkoway H, Negrete M, Palmández P, Bordianu T, Racette BA, Simpson CD. Parkinsonism signs and symptoms in agricultural pesticide handlers in Washington State. Journal of Agromedicine. PMID 28418778 DOI: 10.1080/1059924X.2017.1317684  0.32
2017 Racette BA, Gross A, Criswell SR, Checkoway H, Nielsen SS. A Screening Tool to Detect Clinical Manganese Neurotoxicity. Neurotoxicology. PMID 28274800 DOI: 10.1016/j.neuro.2017.02.009  0.76
2016 Racette BA, Searles Nielsen S, Criswell SR, Sheppard L, Seixas N, Warden MN, Checkoway H. Dose-dependent progression of parkinsonism in manganese-exposed welders. Neurology. PMID 28031394 DOI: 10.1212/WNL.0000000000003533  0.76
2016 Al-Lozi A, Nielsen SS, Hershey T, Birke A, Checkoway H, Criswell SR, Racette BA. Cognitive control dysfunction in workers exposed to manganese-containing welding fume. American Journal of Industrial Medicine. PMID 27862095 DOI: 10.1002/ajim.22675  1
2015 Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging. PMID 26601739 DOI: 10.1016/j.neurobiolaging.2015.09.014  1
2015 Safarpour D, Thibault DP, DeSanto CL, Boyd CM, Dorsey ER, Racette BA, Willis AW. Nursing home and end-of-life care in Parkinson disease. Neurology. 85: 413-9. PMID 26138947 DOI: 10.1212/WNL.0000000000001715  1
2015 Morris M, Willis AW, Searles Nielsen S, McCann F, Birke A, Racette BA. Physician response to a medication alert system in inpatients with levodopa-treated diseases. Neurology. PMID 26092916 DOI: 10.1212/WNL.0000000000001745  1
2015 Racette BA, Willis AW. Time to change the blind men and the elephant approach to Parkinson disease? Neurology. 85: 190-6. PMID 26070339 DOI: 10.1212/WNL.0000000000001739  1
2015 Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. The Lancet. Neurology. 14: 710-9. PMID 26025783 DOI: 10.1016/S1474-4422(15)00058-7  1
2015 Criswell SR, Nelson G, Gonzalez-Cuyar LF, Huang J, Shimony JS, Checkoway H, Simpson CD, Dills R, Seixas NS, Racette BA. Ex vivo magnetic resonance imaging in South African manganese mine workers. Neurotoxicology. 49: 8-14. PMID 25912463 DOI: 10.1016/j.neuro.2015.04.002  1
2015 Searles Nielsen S, Checkoway H, Criswell SR, Farin FM, Stapleton PL, Sheppard L, Racette BA. Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism & Related Disorders. 21: 355-60. PMID 25634431 DOI: 10.1016/j.parkreldis.2015.01.007  1
2015 Baker MG, Criswell SR, Racette BA, Simpson CD, Sheppard L, Checkoway H, Seixas NS. Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees. Scandinavian Journal of Work, Environment & Health. 41: 94-101. PMID 25380186 DOI: 10.5271/sjweh.3466  1
2015 Checkoway H, Nielsen SS, Racette BA. Environmental Exposures and Risks for Parkinson's Disease Environmental Factors in Neurodevelopmental and Neurodegenerative Disorders. 253-265. DOI: 10.1016/B978-0-12-800228-5.00012-1  1
2015 Checkoway H, Nielsen SS, Racette BA. Epidemiological studies of parkinsonism in welders Issues in Toxicology. 2015: 513-523.  1
2014 Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Franklin GM, Swanson PD, Smith-Weller T, Racette BA, Checkoway H. Formulations of hormone therapy and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1631-6. PMID 25255692 DOI: 10.1002/mds.26037  1
2014 Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzi?ska M, Mom?ilovi? D, et al. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Molecular Genetics & Genomic Medicine. 2: 261-72. PMID 24936516 DOI: 10.1002/mgg3.67  1
2014 Racette BA, Holtzman DM, Dall TM, Drogan O. Supply and demand analysis of the current and future US neurology workforce. Neurology. 82: 2254-5. PMID 24935638 DOI: 10.1212/WNL.0000000000000509  1
2014 Baker MG, Simpson CD, Stover B, Sheppard L, Checkoway H, Racette BA, Seixas NS. Blood manganese as an exposure biomarker: state of the evidence. Journal of Occupational and Environmental Hygiene. 11: 210-7. PMID 24579750 DOI: 10.1080/15459624.2013.852280  1
2014 Harris-Hayes M, Willis AW, Klein SE, Czuppon S, Crowner B, Racette BA. Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures. The Journal of Bone and Joint Surgery. American Volume. 96: e27. PMID 24553896 DOI: 10.2106/JBJS.L.01317  1
2014 Gonzalez-Cuyar LF, Nelson G, Criswell SR, Ho P, Lonzanida JA, Checkoway H, Seixas N, Gelman BB, Evanoff BA, Murray J, Zhang J, Racette BA. Quantitative neuropathology associated with chronic manganese exposure in South African mine workers. Neurotoxicology. 45: 260-6. PMID 24374477 DOI: 10.1016/j.neuro.2013.12.008  1
2014 Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 82: 163-71. PMID 24336138 DOI: 10.1212/WNL.0000000000000017  1
2014 Racette BA. Manganism in the 21st century: the Hanninen lecture. Neurotoxicology. 45: 201-7. PMID 24148923 DOI: 10.1016/j.neuro.2013.09.007  1
2014 Czuppon S, Racette BA, Klein SE, Harris-Hayes M. Variables associated with return to sport following anterior cruciate ligament reconstruction: a systematic review. British Journal of Sports Medicine. 48: 356-64. PMID 24124040 DOI: 10.1136/bjsports-2012-091786  1
2014 Lundin JI, Checkoway H, Criswell SR, Hobson AJ, Harris RC, Swisher LM, Evanoff BA, Racette BA. Screening for early detection of parkinsonism using a self-administered questionnaire: a cross-sectional epidemiologic study. Neurotoxicology. 45: 232-7. PMID 24035927 DOI: 10.1016/j.neuro.2013.08.010  1
2013 Nichols MJ, Hartlein JM, Eicken MG, Racette BA, Black KJ. A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease. F1000research. 2: 150. PMID 24627787 DOI: 10.12688/f1000research.2-150.v1  1
2013 Romeo S, Viaggi C, Di Camillo D, Willis AW, Lozzi L, Rocchi C, Capannolo M, Aloisi G, Vaglini F, Maccarone R, Caleo M, Missale C, Racette BA, Corsini GU, Maggio R. Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. Scientific Reports. 3: 1395. PMID 23462874 DOI: 10.1038/srep01395  1
2013 Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C. Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiology of Aging. 34: 1519.e1-2. PMID 23116878 DOI: 10.1016/j.neurobiolaging.2012.10.001  1
2013 Willis AW, Schootman M, Kung N, Racette BA. Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States Parkinsonism and Related Disorders. 19: 202-206. PMID 23083512 DOI: 10.1016/j.parkreldis.2012.09.014  1
2012 Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/srep00954  1
2012 Willis AW, Schootman M, Tran R, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 79: 1774-80. PMID 23054239 DOI: 10.1212/WNL.0b013e3182703f92  1
2012 Klein SE, Dale AM, Hayes MH, Johnson JE, McCormick JJ, Racette BA. Clinical presentation and self-reported patterns of pain and function in patients with plantar heel pain. Foot & Ankle International. 33: 693-8. PMID 22995253 DOI: DOI: 10.3113/FAI.2012.0693  1
2012 Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 33: 1356-61. PMID 22975422 DOI: 10.1016/j.neuro.2012.08.011  1
2012 Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Archives of Neurology. 69: 1326-31. PMID 22825369 DOI: 10.1001/archneurol.2012.1608  1
2012 Criswell SR, Perlmutter JS, Huang JL, Golchin N, Flores HP, Hobson A, Aschner M, Erikson KM, Checkoway H, Racette BA. Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occupational and Environmental Medicine. 69: 437-43. PMID 22447645 DOI: 10.1136/oemed-2011-100119  1
2012 Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Archives of Neurology. 69: 394-7. PMID 22410448 DOI: 10.1001/archneurol.2011.771  1
2012 Nelson G, Criswell SR, Zhang J, Murray J, Racette BA. Research capacity development in South African manganese mines to bridge exposure and neuropathologic outcomes. Neurotoxicology. 33: 683-6. PMID 22313906 DOI: 10.1016/j.neuro.2012.01.003  1
2012 Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Archives of Neurology. 69: 601-7. PMID 22213411 DOI: 10.1001/archneurol.2011.2370  1
2012 Racette BA, Aschner M, Guilarte TR, Dydak U, Criswell SR, Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology. 33: 881-6. PMID 22202748 DOI: 10.1016/j.neuro.2011.12.010  1
2011 Zhu L, Cairns NJ, Tabbal SD, Racette BA. Pregnancy in multiple system atrophy: a case report. Journal of Medical Case Reports. 5: 599. PMID 22208291 DOI: 10.1186/1752-1947-5-599  1
2011 Brenner SR. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 77: e120; author reply e. PMID 22084283 DOI: 10.1212/WNL.0b013e318239bfeb  1
2011 Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: A utilization, outcomes, and survival study Neurology. 77: 851-857. PMID 21832214 DOI: 10.1212/WNL.0b013e31822c9123  1
2011 Harris RC, Lundin JI, Criswell SR, Hobson A, Swisher LM, Evanoff BA, Checkoway H, Racette BA. Effects of parkinsonism on health status in welding exposed workers. Parkinsonism & Related Disorders. 17: 672-6. PMID 21724446 DOI: 10.1016/j.parkreldis.2011.05.021  1
2011 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 549-52. PMID 21370264 DOI: 10.1002/mds.23551  1
2011 Hobson A, Seixas N, Sterling D, Racette BA. Estimation of particulate mass and manganese exposure levels among welders. The Annals of Occupational Hygiene. 55: 113-25. PMID 20870928 DOI: 10.1093/annhyg/meq069  1
2011 Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure Neurology. 76: 1296-1301. DOI: 10.1212/WNL.0b013e3182152830  1
2010 Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488298  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488297  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469-70. PMID 21488296  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469. PMID 21488277  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488252  1
2010 Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, Racette BA. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. American Journal of Epidemiology. 172: 1357-63. PMID 20959505 DOI: 10.1093/aje/kwq303  1
2010 Crowner BE, Torres-Russotto D, Carter AR, Racette BA. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clinical Neuropharmacology. 33: 243-7. PMID 20852412 DOI: 10.1097/WNF.0b013e3181f5329e  1
2010 Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 34: 143-51. PMID 20090375 DOI: 10.1159/000275491  1
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. Novel THAP1 sequence variants in primary dystonia. Neurology. 74: 229-38. PMID 20083799 DOI: 10.1212/WNL.0b013e3181ca00ca  1
2010 Criswell S, Sterling C, Swisher L, Evanoff B, Racette BA. Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders. Parkinsonism & Related Disorders. 16: 197-201. PMID 20005766 DOI: 10.1016/j.parkreldis.2009.11.007  1
2010 Willis AW, Sterling C, Racette BA. Conjugal Parkinsonism and Parkinson disease: a case series with environmental risk factor analysis. Parkinsonism & Related Disorders. 16: 163-6. PMID 19818671 DOI: 10.1016/j.parkreldis.2009.09.002  1
2009 Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, ... ... Racette BA, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 41: 1308-12. PMID 19915575 DOI: 10.1038/ng.487  1
2009 Racette BA, Good LM, Kissel AM, Criswell SR, Perlmutter JS. A population-based study of parkinsonism in an Amish community. Neuroepidemiology. 33: 225-30. PMID 19641327 DOI: 10.1159/000229776  1
2009 Hobson AJ, Sterling DA, Emo B, Evanoff BA, Sterling CS, Good L, Seixas N, Checkoway H, Racette BA. Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders. Journal of Occupational and Environmental Hygiene. 6: 324-31. PMID 19288335 DOI: 10.1080/15459620902836856  1
2009 Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, et al. High-throughput mutational analysis of TOR1A in primary dystonia. Bmc Medical Genetics. 10: 24. PMID 19284587 DOI: 10.1186/1471-2350-10-24  1
2009 Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Parkinsonism & Related Disorders. 15: 175-80. PMID 18752982 DOI: 10.1016/j.parkreldis.2008.05.004  1
2008 Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32  1
2008 Crowner BE, Racette BA. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Pediatric Neurology. 39: 253-8. PMID 18805363 DOI: 10.1016/j.pediatrneurol.2008.07.003  1
2008 McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/mds.22186  1
2008 DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/s00439-008-0526-4  1
2008 Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.wnl.0000304051.01650.23  1
2008 Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics. 17: 759-67. PMID 18063669 DOI: 10.1093/hmg/ddm348  1
2007 Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Developmental Medicine and Child Neurology. 49: 818-22. PMID 17979859 DOI: 10.1111/j.1469-8749.2007.00818.x  1
2007 Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clinical Neuropharmacology. 30: 310-3. PMID 17909312 DOI: 10.1097/WNF.0b013e31804b1a0d  1
2007 Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. Association of α-synuclein gene haplotypes with Parkinson's disease Parkinsonism and Related Disorders. 13: 343-347. PMID 17292657 DOI: 10.1016/j.parkreldis.2006.12.006  1
2007 Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, ... ... Racette B, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.wnl.0000250355.28474.8e  1
2007 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. Reply from the authors [6] Neurology. 69: 495-496. DOI: 10.1212/01.wnl.0000279165.72261.d0  1
2006 Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, ... ... Racette BA, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.wnl.0000249149.22407.d1  1
2006 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. The impact of litigation on neurologic research. Neurology. 67: 2124-8. PMID 17190932 DOI: 10.1212/01.wnl.0000249306.85048.86  1
2006 Criswell SR, Crowner BE, Racette BA. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy. Neurosurgical Focus. 21: e1. PMID 16918222  1
2006 Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/archneur.63.6.826  1
2006 Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1175-81. PMID 16673404 DOI: 10.1002/mds.20919  1
2006 Racette BA, Good L, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Perlmutter JS. [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 245-9. PMID 16528749 DOI: 10.1002/ajmg.b.30293  1
2006 Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology. 27: 357-61. PMID 16376428 DOI: 10.1016/j.neuro.2005.11.005  1
2006 Racette BA, Perlmutter JS, Evanoff BA. Reply from the Authors [12] Neurology. 66: 617. DOI: 10.1212/01.wnl.0000216108.57529.b1  1
2005 Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.wnl.0000187075.81589.fd  1
2005 Sinha R, Racette B, Perlmutter JS, Parsian A. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease Parkinsonism and Related Disorders. 11: 341-347. PMID 16019250 DOI: 10.1016/j.parkreldis.2005.04.003  1
2005 Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, ... ... Racette BA, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/mds.20515  1
2005 Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders Neurology. 64: 230-235. PMID 15668418  1
2005 Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 492-6. PMID 15648057 DOI: 10.1002/mds.20381  1
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/mds.20332  1
2004 Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS. Pathophysiology of parkinsonism due to hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1617-9. PMID 15489399 DOI: 10.1136/jnnp.2003.028449  1
2004 Pastor P, Ezquerra M, Perez JC, Chakraverty S, Norton J, Racette BA, McKeel D, Perlmutter JS, Tolosa E, Goate AM. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Annals of Neurology. 56: 249-58. PMID 15293277 DOI: 10.1002/ana.20178  1
2004 Smith JL, Ju JS, Saha BM, Racette BA, Fisher JS. Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle. Journal of Applied Physiology (Bethesda, Md. : 1985). 97: 2339-46. PMID 15258132 DOI: 10.1152/japplphysiol.01219.2003  1
2004 Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease Parkinsonism and Related Disorders. 10: 213-219. PMID 15120095 DOI: 10.1016/j.parkreldis.2003.12.003  1
2004 Parsian A, Racette B, Zhang ZH, Rundle M, Perlmutter JS. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups Genomics. 83: 454-460. PMID 14962671 DOI: 10.1016/j.ygeno.2003.09.002  1
2003 Hou CE, Schlaggar BL, Racette BA. Dystonia in a patient with ring chromosome 21. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1547-9. PMID 14673898 DOI: 10.1002/mds.10621  1
2003 Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, ... ... Racette BA, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042  1
2003 Racette BA, Good L, Sagitto S, Perlmutter JS. Botulinum toxin B reduces sialorrhea in parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1059-61. PMID 14502678 DOI: 10.1002/mds.10484  1
2003 Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A, Shults CW, Conneally PM, Foroud T. Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Human Molecular Genetics. 12: 2599-608. PMID 12925570 DOI: 10.1093/hmg/ddg270  1
2002 Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection Neurology. 59: 1445-1447. PMID 12427903  1
2002 Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 438-42. PMID 12426412 DOI: 10.1176/appi.neuropsych.14.4.438  1
2002 Racette BA, Stambuk M, Perlmutter JS. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024). Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1098-100. PMID 12360571 DOI: 10.1002/mds.10209  1
2002 Nichols WC, Pankratz N, Uniacke SK, Pauciulo MW, Halter C, Rudolph A, Conneally PM, Foroud T. Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families. Journal of Medical Genetics. 39: 489-92. PMID 12114481  1
2002 Racette BA, Rundle M, Wang JC, Goate A, Saccone NL, Farrer M, Lincoln S, Hussey J, Smemo S, Lin J, Suarez B, Parsian A, Perlmutter JS. A multi-incident, Old-Order Amish family with PD. Neurology. 58: 568-74. PMID 11865134  1
2002 Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: Possible association with dementia but not age at onset Genomics. 79: 458-461. PMID 11863377 DOI: 10.1006/geno.2002.6707  1
2001 Racette BA, Perry A, D'Avossa G, Perlmutter JS. Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum Movement Disorders. 16: 1148-1152. PMID 11748751 DOI: 10.1002/mds.10012  1
2001 Racette BA. Welding-related Parkinsonism: Clinical features, treatment, and pathophysiology [1] Neurology. 57: 936-937. PMID 11575307  1
2001 Racette BA, Dowling J, Randle J, Mink JW. Thalamic stimulation for primary writing tremor. Journal of Neurology. 248: 380-2. PMID 11437158 DOI: 10.1007/s004150170177  1
2001 Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 56: 8-13. PMID 11148228  1
2000 Racette BA, Rich KM, Randle J, Mink JW. Ipsilateral thalamic stimulation after thalamotomy for essential tremor. A case report. Stereotactic and Functional Neurosurgery. 75: 155-9. PMID 11910208 DOI: 10.1159/000048400  1
2000 Racette BA. Chorea and jaw-opening dystonia as a manifestation of NeuroBehcet's syndrome Movement Disorders. 15: 741-744. PMID 10928591 DOI: 10.1002/1531-8257(200007)15:4<741::AID-MDS1025>3.0.CO;2-5  1
1999 Racette BA, McGee-Minnich L, Perlmutter JS. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation Clinical Neuropharmacology. 22: 337-339. PMID 10626093  1
1999 Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 7: 169-74. PMID 10520242  1
1999 Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 88: 539-543. PMID 10490713 DOI: 10.1002/(SICI)1096-8628(19991015)88:5<539::AID-AJMG19>3.0.CO;2-S  1
1998 Racette BA, Perlmutter JS. Levodopa responsive parkinsonism in an adult with Huntington's disease Journal of Neurology Neurosurgery and Psychiatry. 65: 577-579. PMID 9771791  1
1998 Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases Journal of Neurosurgery. 88: 328-330. PMID 9452245  1
Show low-probability matches.